Related Experiment Video
Updated: Jul 4, 2026
08:17
Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Maxadilan, the PAC1 receptor, and leishmaniasis
Vemuri B Reddy1, Yhong Li, Ethan A Lerner
1Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Building 149, 13th Street, Chareleston, MA 02129, USA.
Journal of Molecular Neuroscience : MN
|May 30, 2008
Summary
Maxadilan, a peptide from sand flies, widens blood vessels via the PAC1 receptor. This aids parasite transmission and leishmaniasis infectivity.
Area of Science:
- Parasitology
- Molecular Biology
- Vascular Pharmacology
Background:
- Sand flies transmit leishmaniasis, a significant parasitic disease.
- Maxadilan is a salivary peptide from sand flies with vasodilatory properties.
- The PAC1 receptor mediates maxadilan's vascular effects, despite lacking sequence homology with PACAP.
Purpose of the Study:
- To discuss the role of maxadilan in sand fly feeding and parasite transmission.
- To explore the interaction between maxadilan, the PAC1 receptor, and leishmania parasites.
- To provide an overview of maxadilan, PAC1 receptor, and leishmaniasis.
Main Methods:
- Literature review and discussion of existing research on maxadilan.
- Analysis of the molecular interactions between maxadilan and the PAC1 receptor.
- Examination of the physiological role of maxadilan in sand fly-parasite-host interactions.
Main Results:
- Maxadilan acts as a vasodilator, facilitating blood acquisition by sand flies.
- The PAC1 receptor is the primary mediator of maxadilan's vasodilatory effects.
- Maxadilan enhances the infectivity of leishmania parasites transmitted by sand flies.
Conclusions:
- Maxadilan plays a dual role in the leishmaniasis transmission cycle.
- Understanding maxadilan-PAC1 receptor interactions is crucial for leishmaniasis control strategies.
- The peptide contributes to both vector feeding success and parasite infectivity.
Related Concept Videos
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...